BROOKFIELD, Wis. — February 26, 2019 – Connecture, Inc. announces the sales of its Commercial U65 business unit to Benefitfocus
With the sale of the U65 business, Connecture ensures a dedicated focus on its Medicare business, which includes the PlanCompare, Brokerlink, and DrugCompare platforms. With this now exclusively SaaS suite of solutions, Connecture is positioned to more efficiently target investments that will enable its customers’ evolution and growth in the Medicare and drug price comparison spaces.
“The Commercial business unit has done a great job delivering, innovating and launching tools and platforms that fit nicely alongside the Benefitfocus portfolio,” said Kraig McEwen, CEO of Connecture.
“This is a signal of both our renewed laser focus on our Medicare business and the vibrancy of the Commercial business which is now part of Benefitfocus. We look forward to partnering during this period of transition and continuing to support market success for our customers.”read more
Connecture’s SVP of Federal Programs Jim Yocum spoke with Money Magazine to discuss some of the potential implications from the White House’s recent efforts to curb drug costs. Connecture data was used in the analysis.read more
As Millennials make up a growing portion of the American workforce, shifts in information security practices and business objectives must occur to keep up with how they interact with the digital landscape. This means continually minimizing, monitoring and managing sensitive data — especially health care data — to shield it from cyber threats.read more
Telehealth services are becoming the “go-to” choice for many Americans, including Medicare beneficiaries. In this article, which summarizes an interview our own Jim Yocum did with Bloomberg Law, the journalist explains why CMS supports telehealth benefits as part of their Medicare strategy.read more
In a recent Bloomberg article, the writers show how prescription drug prices are moving up at a rate at least four times CPI inflation. Connecture data used to help construct Bloomberg’s new Drug Price Index.read more
A recent article from CNN highlights the obstacles many people with Type 1 diabetes face when it comes to rising drug costs (particularly insulin, in this case). Connecture’s prescription drug data was used and cited in the article.read more
The Connecture Team was in San Diego last month for the AHIP Institute & Expo — one of the biggest healthcare events of the year. During the three-day event, our own Jeff Surges took the stage with our client Jerry Eichhorst from USAA, to talk about the future of healthcare consumerism. A reporter from Healthcare Finance attended the session and wrote a recap of Jeff’s remarks.read more
Medicare Advantage plans are realizing that increased competition means they need to keep members engaged year-round. In this article published in AIS Health’s Radar on Medicare Advantage, our own Jeff Surges provides his insight on what carriers need to think about when it comes to an effective engagement strategy. Our client Geisinger Health Plan is also featured in this piece.read more
Employee Benefit News interviewed the Hy-Vee and Connecture teams about their recent partnership and the impact of Hy-Vee’s new benefits marketplace.read more
One new idea on mitigating higher drug prices is to require the posting of costs in Rx advertising. This Kaiser Health News article provides illustrative examples of how this might look for the 10 drugs with the highest annual ad spend. Connecture data used.read more